Page 472 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 472

428        SectIon III    Hematology and oncology   ` hematology and oncology—Pathology                                                   Hematology and oncology   ` hematology and oncology—Pathology





               Mixed platelet and coagulation disorders
                dISoRdeR             Pc         Bt         Pt        Ptt        noteS
                von Willebrand       —                    —         —/        Intrinsic pathway coagulation defect:  vWF
                 disease                                                         Ž  PTT (vWF carries/protects factor VIII).
                                                                                Defect in platelet plug formation:  vWF
                                                                                 Ž defect in platelet-to-vWF adhesion.
                                                                                Autosomal dominant. Mild but most common
                                                                                 inherited bleeding disorder. No platelet
                                                                                 aggregation with ristocetin cofactor assay.
                                                                                 Treatment: desmopressin, which releases
                                                                                 vWF stored in endothelium.
                Disseminated                                                Widespread clotting factor activation
                 intravascular                                                   Ž deficiency in clotting factors Ž bleeding
                 coagulation                                                     state.
                                                                                Causes: Snake bites, Sepsis (gram ⊝),
                                                                                 Trauma, Obstetric complications, acute
                                                                                 Pancreatitis, Malignancy, Nephrotic
                                                                                 syndrome, Transfusion (SSTOP Making
                                                                                 New Thrombi).
                                                                                Labs: schistocytes,  fibrin degradation
                                                                                 products (d-dimers),  fibrinogen,  factors V
                                                                                 and VIII.



               Hereditary thrombosis syndromes leading to hypercoagulability
                dISeaSe              deScRIPtIon
                Antithrombin         Autosomal dominant inherited deficiency of antithrombin: has no direct effect on the PT, PTT, or
                 deficiency            thrombin time but diminishes the increase in PTT following heparin administration.
                                     Can also be acquired: renal failure/nephrotic syndrome Ž antithrombin loss in urine
                                       Ž  inhibition of factors IIa and Xa.
                Factor V Leiden      Autosomal dominant, most common cause of inherited hypercoagulability in Caucasians.
                                       Production of mutant factor V (guanine Ž adenine DNA point mutation Ž Arg506Gln mutation
                                       near the cleavage site) that is resistant to degradation by activated protein C. Complications
                                       include DVT, cerebral vein thrombosis, recurrent pregnancy loss.

                Protein C or S        ability to inactivate factors Va and VIIIa.  risk of thrombotic skin necrosis with hemorrhage
                 deficiency            after administration of warfarin. If this occurs, think protein C deficiency. Together, protein C
                                       Cancels, and protein S Stops, coagulation.
                Prothrombin gene     Mutation in 3′ untranslated region Ž  production of prothrombin Ž  plasma levels and venous
                 mutation             clots.

























          FAS1_2019_10-HemaOncol.indd   428                                                                             11/7/19   5:05 PM
   467   468   469   470   471   472   473   474   475   476   477